Streptococcus pneumoniae is the leading cause worldwide of community-and hospital-acquired pneumonia. 1, 2 Otitis media, sinusitis, mastoiditis, and meningitis are also frequently caused by pneumococci. 3 Several risk factors have been associated with invasive pneumococcal disease, including chronic cardiovascular or pulmonary disease, alcoholic liver disease, dementia, diabetes mellitus, and asplenia. 1, 4 In the United States, it is estimated there are 3,000 cases of pneumococcal meningitis, 50,000 of pneumococcal bacteremia, and 500,000 of pneumococcal pneumonia annually. 4 These infections cause an estimated 40,000 deaths, with highest mortality in patients with meningitis and bacteremia.
Cultures are the reference diagnostic standard for pneumococcal disease. However, S pneumoniae can be cultured from the upper respiratory tract in as many as 68% of children and 15% of adults in the absence of respiratory disease. 3, 5 In addition, people with pneumococcal infections who are receiving antibiotics can have negative culture results. 6 Thus, a variety of other diagnostic methods, including antigen testing and polymerase chain reaction (PCR), applied to different clinical specimens such as urine, blood, bronchoalveolar lavage fluid, and transthoracic needle aspirates have been used to define invasive and noninvasive pneumococcal disease. [7] [8] [9] [10] [11] [12] [13] Fatal infections potentially caused by S pneumoniae are often found at autopsy. If specimens for microbiologic culture were not obtained before death or at autopsy or if they were obtained but yielded negative or ambiguous results, formalinfixed tissue samples might be the only specimens available for analysis. Traditionally, bacteria have been detected in formalinfixed tissue samples using Gram stain or silver impregnation stains, which do not allow identification of species specific organisms. Thus, diagnostic methods that permit specific detection of S pneumoniae in formalin-fixed tissue samples, such as immunohistochemical analysis, can be of great value. In addition, immunohistochemical assays allow detection of bacteria and their antigens in the context of the host inflammatory reaction helping differentiate colonizers from pathogens. 14, 15 We describe the usefulness of an immunohistochemical assay for S pneumoniae in biopsy and autopsy formalin-fixed tissue samples and compared the immunohistochemical assay to conventional culture and Gram stain techniques.
Materials and Methods
We studied 46 cases in which an S pneumoniae immunohistochemical assay had been applied to formalin-fixed samples and for which results of premortem or postmortem bacterial cultures were available. The cases had been submitted to the Centers for Disease Control and Prevention (CDC), Atlanta, GA, for consultation or as part of a medical examiner surveillance system. 16 Demographic and clinical data varied in completeness. H&E stains were performed on representative sections from all cases. Brown Brenn Gram stain 17 and immunohistochemical assays were performed on a variety of tissue sections from paraffin blocks that showed inflammatory foci and on tissue sections from spleen and adrenal glands. Gram and immunohistochemical sections were reviewed in a nonblinded manner and compared with Gram stain and culture results to determine the sensitivity, specificity, and positive and negative predictive values.
Immunohistochemical Assays
Immunohistochemical assays were performed on deparaffinized, rehydrated 3-µm sections of tissue samples as previously described for other infectious agents. 14, 15, 18 Tissue sections were processed in a DAKO autostainer (DakoCytomation, Carpinteria, CA) in which digestion with Proteinase K (Roche, Indianapolis, IN), incubation with a polyclonal rabbit antibody against S pneumoniae (Respiratory Disease Branch, CDC), and colorimetric detection (LSAB2 Universal alkaline phosphatase kit, DAKO, Carpinteria, CA) were performed. Sections were counterstained with Mayer hematoxylin (Fisher Scientific, Pittsburgh, PA). Negative control samples consisted of sequential case tissue sections incubated with normal rabbit serum as the primary antibody. Interpretation of immunohistochemical results included the location of the positive reaction and the staining pattern (welldefined cocci vs granular staining).
The primary antibody was produced by immunizing rabbits with PsaA-purified protein from S pneumoniae 22F. 19 The antibody was titrated to a 1:3,000 working dilution using formalinfixed, paraffin-embedded cultures of S pneumoniae. No reactivity of the primary antibody was found with formalin-fixed, 
Polymerase Chain Reaction
For cases with positive immunohistochemical results for S pneumoniae but without culture confirmation, DNA was extracted from 10-µm paraffin-embedded tissue sections that showed pneumococcal antigens. Sections were deparaffinized, air dried, and incubated overnight at 56°C in 180 µL of lysis buffer ATL and 20 µL of Proteinase K. Extraction was performed with the QIAmp DNA mini kit (Qiagen, Valencia, CA). The extracts were tested by using a real-time PCR assay for the ltyA gene of S pneumoniae. 20, 21 
Results
Positive immunohistochemical staining for S pneumoniae was present in samples from 26 patients, 18 of which had evidence of S pneumoniae from cultures and 8 had cultures that grew mixed bacteria or had no growth. ❚Table 1❚ gives demographic data, risk factors for infection, clinical manifestations, pathologic findings, and culture results for the 26 patients with positive immunohistochemical results for S pneumoniae. All patients were adults except for a 21-week-gestation neonate who died with pneumonia 30 minutes after birth. The mother had a history of injecting drug use and had been assaulted 1 week before delivery; the placenta showed chorioamnionitis. All patients had at least 1 risk factor for S pneumoniae infection. The most common risk factor for patients with culture confirmation of S pneumoniae was alcoholic liver disease and for patients without culture confirmation was injecting drug use. Only 3 patients had S pneumoniae cultured before death, including the only surviving patient, a 55-year-old man with vertebral osteomyelitis in whom S pneumoniae was isolated from the blood but not from the cervical bone fine-needle aspirate and biopsy specimens. Of the 8 patients without S pneumoniae culture confirmation, 2 had received multiple antibiotics because of recurrent pneumonic episodes. In these 8 patients, S pneumoniae was confirmed by using a real-time PCR assay for the ltyA gene of S pneumoniae. 21 Pneumonia was observed in 16 of 18 patients with S pneumoniae culture confirmation and 7 of 8 without culture confirmation. Four patients had meningitis, 3 of whom had concomitant evidence of pneumonia. Adrenal gland hemorrhage was noted in 4 of 7 cases evaluated. Small abscesses in the myocardium were observed in 1 of 16 hearts examined. Gram-positive cocci in areas of inflammation were observed in 11 immunohistochemically positive cases (7 with S pneumoniae cultures). Gram-variable cocci, sometimes accompanied by gram-positive cocci, were observed in 4 cases (all with S pneumoniae cultures). Gram stains were noncontributory in 7 cases with S pneumoniae cultured and 4 without culture confirmation.
Pneumococci and pneumococcal antigens were abundant in the areas of the lung showing intra-alveolar inflammation (23 cases) ❚Image 1A❚, sometimes extending onto the pleural surfaces ❚Image 1B❚. In the 4 patients with meningeal inflammation, pneumococci and pneumococcal antigens were observed inside neutrophils and macrophages in the meninges and in the subarachnoid space ❚Image 1C❚. Spleen was available for study in 9 cases; 4 showed pneumococcal antigens in sinusoids ❚Image 1D❚. Liver was available for study in 7 cases; 4 showed pneumococci and pneumococcal antigens in Kupffer cells. Of the 7 kidneys, 3 studied showed pneumococcal antigens in vessels and glomeruli. Pneumococci and pneumococcal antigens were observed in 3 adrenal glands, all 3 with adrenal gland hemorrhage. Pneumococci and pneumococcal antigens were observed in the heart with multiple microabscesses. In the patient with osteomyelitis, pneumococci and pneumococcal antigens were observed inside the mononuclear inflammatory cells present in the cervical bone biopsy ❚Image 1E❚. In the neonate, pneumococci and pneumococcal antigens were present in bronchioles, alveoli ❚Image 1F❚, and the fetal side of the amniotic membranes but not in the placenta, liver, spleen, kidney, or brain. Last, 1 patient without pneumonia or meningitis had pneumococci and pneumococcal antigens in the blood vessels of lung, skin, and lymph nodes and inside liver Kupffer cells, suggesting septicemia.
❚Table 2❚ gives demographic data and pathologic diagnoses for the 20 cases that showed negative immunohistochemical staining for S pneumoniae and grew other bacteria (9 with S aureus, 7 with Streptococcus pyogenes, and 4 with H influenzae). The mean age of these patients was younger than that of patients with immunohistochemical results positive for S pneumoniae, correlating with the typical age range for invasive S aureus-, S pyogenes-, and H influenzae-associated diseases. Similar to the S pneumoniae cases, pneumonia was the predominant pathologic diagnosis. Ten cases showed grampositive cocci, including 2 that had H influenzae cultures. The gram-positive cocci in the H influenzae cases were present in upper airways and were not associated with inflammation.
❚Table 3❚ gives sensitivity, specificity, and positive and negative predictive values for the different methods using culture and immunohistochemical staining as the reference standard. The immunohistochemical assay showed 100% sensitivity and negative predictive value. Cultures had 100% specificity and positive predictive value. The Gram stain showed sensitivity and specificity values of 61% or less.
Discussion
This study demonstrated the usefulness of a novel immunohistochemical assay for the detection of S pneumoniae in formalin-fixed tissue samples. Our test cases were selected because premortem or postmortem cultures were available allowing calculation of sensitivity and specificity of the assay. The sensitivity and negative predictive value of the S pneumoniae immunohistochemical test were excellent. However, specificity and positive predictive value of the immunohistochemical test were affected by diagnostic limitations imposed by using cultures as the reference standard. 6 Negative or noncontributory culture results in 8 cases could be attributed in part to antibiotic use or failure to further identify the species in mixed cultures. The immunohistochemical assays permitted detection of pneumococci in areas of pathologic change compatible with pneumococcal disease such as pneumonia and meningitis. PCR assays identified S pneumoniae genes in these 8 cases. In this context, the 8 cases without culture confirmation for S pneumoniae represent falsenegative culture results.
In comparison with the immunohistochemical assay, tissue Gram stains showed considerably lower sensitivity and specificity for identifying S pneumoniae in formalin-fixed samples. The low specificity was expected because we included cases with infections by other gram-positive cocci (S aureus and S pyogenes) for the statistical analyses. The low sensitivity of tissue Gram stains for S pneumoniae can be explained by the changes that bacteria undergo inside host phagocytic cells, how long the bacteria have been in the host, and the effect of bacterial enzymes, such as autolysin and pneumolysin, in the bacterial cell wall. 22 In our series, 7 patients were considered to have pneumonia of unknown cause and 1 had meningitis without a causative microorganism until the S pneumoniae immunohistochemical assay was performed. Our results suggest that pneumococcal pneumonia is probably more frequent than currently appreciated. S pneumoniae is the most frequently identified pathogen in patients with pneumonia (approximately 20%); other agents that cause pneumonia include S pyogenes, H influenzae, and S aureus. It is estimated that a causative pathogen is not identified in 50% of cases of pneumonia. In general, the lack of organism-specific diagnosis in cases of pneumonia is due to several factors, including the different yields from microbiologic tests and the different guidelines and practices in the treatment of patients. [7] [8] [9] [10] [11] [12] [13] 23 The problem is compounded because acute bronchopneumonia is the most common infection missed clinically but detected at autopsy. 24 Pathogen-specific diagnosis is important for patient treatment, to epidemiologically define an etiologic agent during outbreaks or nosocomial infections, to guide appropriate infection control activities, and to assess trends in morbidity and mortality attributable to the different infectious agents. For pneumococcal disease in particular, specific diagnosis of cases is of great importance to better define groups of patients at risk in whom pneumonia could have potentially been prevented by the polysaccharide pneumococcal vaccine. By using immunohistochemical analysis as the reference standard method for diagnosis, we found that cultures were specific but not sensitive. Microbiologic culture of blood or other normally sterile fluids is considered the reference standard for defining invasive pneumococcal disease; however, this technique can be inadequate and limiting. 7, 11 In addition, cultures are not routinely obtained in autopsies of persons who die at home or in the hospital of natural causes. Therefore, immunohistochemical assays are an important adjunctive test that could be used to diagnose suspected fatal cases of pneumococcal disease when cultures have not been performed or when the results are ambiguous.
In our series, most cases had pneumococcal pneumonia and only a small percentage had bacteremia, meningitis, or osteomyelitis. S pneumoniae is a frequent colonizer of the naso-oropharyngeal mucosa, yet pneumonia and meningitis are only seen in a subset of cases. 5, 22 Several bacterial factors such as choline binding protein A and neuraminidase A are required for the transition from the upper respiratory tract to the lungs, whereas bacterial replication in the blood requires pneumolysin and autolysin. 22 Host factors, including cytokines (tumor necrosis factor α) and cells (neutrophils and T lymphocytes) are important to contain the disease process. 25, 26 Waterhouse-Friderichsen syndrome is characterized by septicemia, shock, cutaneous petechiae and/or purpura, and adrenocortical insufficiency. 27 Although Waterhouse-Friderichsen syndrome is classically associated with meningococcemia, other infectious agents, such as H influenzae and S pneumoniae, can cause a similar clinical and pathologic picture. 15 Hemorrhage and necrosis of the adrenal cortex are the cause of adrenocortical insufficiency, whereas cutaneous manifestations have been attributed to leukocytoclastic vasculitis. Finding bacteria in adrenal glands has been difficult with the use of special stains. By using the immunohistochemical assay, pneumococcal antigens were frequently detected in hemorrhagic adrenal glands and not in nonhemorrhagic adrenals. This finding suggests that pneumococcal antigens may be important in the pathogenesis of Waterhouse-Friderichsen syndrome; a similar process is seen in patients with adrenal hemorrhage associated with meningococcal or group A streptococcal infections. 15, 18 The usefulness of an immunohistochemical assay for S pneumoniae using formalin-fixed specimens in the clinical management of patients is highlighted by the information obtained from the cervical bone biopsy specimen of the patient with osteomyelitis. In the patient, a culture of a fine-needle aspirate of the vertebral bone did not grow bacteria; however, S pneumoniae had been isolated from the blood 4 days earlier. The immunohistochemical assay of the cervical bone biopsy specimen demonstrated pneumococci and pneumococcal antigens in areas of chronic osteomyelitis, a rare complication of pneumococcal infection. 28 This information provided a specific diagnosis of S pneumoniae osteomyelitis and indicated the need for prolonged intravenous antibiotic treatment.
The immunohistochemical assay was also useful to explain the route of infection and cause of neonatal death. Pneumococci and pneumococcal antigens were present in the fetal side of the amnion but not in the maternal side or placenta, indicating that the mother was not bacteremic. In the neonate, pneumococci or pneumococcal antigens were present in the lungs but not in the liver, kidney, or brain. The localization of the pneumococci suggested that the neonate aspirated the bacteria present in the amniotic fluid. S pneumoniae is not considered part of the normal vaginal flora; however, it has been reported as a cause of chorioamnionitis and premature rupture of membranes. 29, 30 In our study, we were able to identify pneumococcal disease by using immunohistochemical analysis when cultures were noncontributory. Immunohistochemical assays and PCR performed on formalin-fixed, paraffin-embedded tissue samples offered advantages, such as allowing specific diagnosis of S pneumoniae, permitting the use of archival paraffin blocks, using specimens that pose minimal biohazard for the laboratory personnel handling them, and permitting study of pathogenic mechanisms. Our study highlights the strengths and weaknesses of widely used tests for S pneumoniae, such as cultures and Gram stains, and underscores the need to develop newer immunohistochemical assays that can be applied to formalin-fixed tissue samples and depend on monoclonal antibodies that would facilitate their dissemination and applicability in hospital settings. Immunohistochemical and PCR confirmatory testing of formalin-fixed tissue samples is available at the CDC through the Infectious Disease Pathology Activity. Because infections by S pneumoniae are frequent and the immunohistochemical and PCR tests are currently available at the CDC, selection of cases for testing will take into consideration public health importance and diagnostic and treatment dilemmas.
We developed and applied to formalin-fixed tissue samples a novel S pneumoniae immunohistochemical assay. This assay will be useful in cases for which culture samples were not obtained or when culture results are ambiguous or potentially false-negative. Immunohistochemical analysis is advantageous because it allows visualization of pneumococci and pneumococcal antigens while preserving morphologic features, and it enables a better understanding of how S pneumoniae causes disease. 
